Eli Lilly and Company (LLY)

Eli Lilly Stock Forecast

Stock Price Forecast

According to 30 analysts polled by S&P Global, Eli Lilly stock has a consensus rating of "Buy" and an average price target of $1,256. The average 1-year stock price forecast is 7.41% higher than the current stock price, while the lowest is $850 (-27.30%) and the highest is $1,500 (+28.30%).

Price Target: $1,256 (+7.41%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$850	$1,256	$1,300	$1,500
Change	-27.30%	+7.41%	+11.19%	+28.30%

Analyst Ratings

The average analyst rating for Eli Lilly stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Feb '26	Mar '26	Apr '26	May '26	Jun '26	Jul '26
Strong Buy	18	18	18	18	17	17
Buy	6	6	6	6	6	6
Hold	6	6	6	5	5	5
Sell	1	0	0	1	1	1
Strong Sell	0	1	1	1	1	1
Total	31	31	31	31	30	30

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Geoff Meacham Citi	Citi	Buy Reiterates $1,500 → $1,600	Buy	Reiterates	$1,500 → $1,600	+36.85%	Jul 15, 2026
Courtney Breen Bernstein	Bernstein	Buy Reiterates $1,300 → $1,385	Buy	Reiterates	$1,300 → $1,385	+18.46%	Jul 14, 2026
Michael Yee UBS	UBS	Buy Reiterates $1,250 → $1,425	Buy	Reiterates	$1,250 → $1,425	+21.88%	Jul 13, 2026
Evan Seigerman BMO Capital	BMO Capital	Buy Maintains $1,300	Buy	Maintains	$1,300	+11.19%	Jul 13, 2026
Seamus Fernandez Guggenheim	Guggenheim	Buy Reiterates $1,235 → $1,273	Buy	Reiterates	$1,235 → $1,273	+8.88%	Jul 13, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

85.47B

Increased by 31.12%

from 65.18B

Revenue Next Year

98.82B

Increased by 15.63%

from 85.47B

EPS This Year

35.60

Increased by 47.03%

from 24.21

EPS Next Year

44.98

Increased by 26.37%

from 35.60

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	28.32B	28.54B	34.12B	45.04B	65.18B	85.47B
Revenue Growth	15.40%	0.79%	19.56%	32.00%	44.70%	31.12%
Gross Profit	21.35B	21.91B	27.04B	36.63B	54.13B	71.15B
Gross Margin	75.38%	76.77%	79.25%	81.31%	83.04%	83.25%
Operating Income	8.27B	8.65B	10.33B	17.04B	29.70B	40.00B
Net Income	5.58B	6.24B	5.24B	10.59B	20.64B	31.02B
EPS	-	-	-	-	24.21	35.60
EPS Growth	-	-	-	-	86.37%	47.03%
Forward PE	31.77	46.27	53.37	35.13	34.33	32.85
Dividend / Share	3.40	3.92	4.52	5.20	6.00	6.77
Dividend Growth	-	15.29%	15.31%	15.04%	15.38%	12.76%
Free Cash Flow	5.46B	5.28B	292.33M	1.35B	1.95B	23.23B
No. Analysts	-	-	-	-	-	25

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	93.1B
Avg	85.5B
Low	83.0B

Revenue Growth

Revenue Growth	2026	2027	2028
High	42.8%
Avg	31.1%
Low	27.4%

EPS Forecast

EPS	2026	2027	2028
High	39.78
Avg	35.60
Low	27.66

EPS Growth

EPS Growth	2026	2027	2028
High	64.3%
Avg	47.0%
Low	14.3%

Data Sources: S&P Global Market Intelligence and TipRanks Last updated: Jul 15, 2026

Price targets, consensus ratings and financial forecasts are provided by S&P Global Market Intelligence. Individual analyst data is provided by TipRanks. Price targets and consensus ratings update every hour to every three days, while individual analyst data updates in near real-time.

Last checked:

Jul 15, 2026

Data Sources Report a data error